Medicure Price To Book vs. EBITDA

MPH Stock  CAD 0.98  0.01  1.01%   
Based on the measurements of profitability obtained from Medicure's financial statements, Medicure may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Medicure's ability to earn profits and add value for shareholders. At this time, Medicure's EV To Sales is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 0.29 in 2024, whereas Days Sales Outstanding is likely to drop 76.63 in 2024. At this time, Medicure's Net Interest Income is fairly stable compared to the past year. Change To Netincome is likely to climb to about 100.2 K in 2024, whereas Operating Income is likely to drop (896.7 K) in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.850.6448
Significantly Up
Slightly volatile
For Medicure profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medicure to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medicure utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medicure's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medicure over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Medicure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medicure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medicure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Medicure EBITDA vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Medicure's current stock value. Our valuation model uses many indicators to compare Medicure value to that of its competitors to determine the firm's financial worth.
Medicure is regarded fourth in price to book category among its peers. It also is regarded fourth in ebitda category among its peers totaling about  2,545,455  of EBITDA per Price To Book. At this time, Medicure's EBITDA is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicure's earnings, one of the primary drivers of an investment's value.

Medicure EBITDA vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Medicure

P/B

 = 

MV Per Share

BV Per Share

 = 
0.52 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Medicure

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
1.32 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Medicure EBITDA Comparison

Medicure is currently under evaluation in ebitda category among its peers.

Medicure Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Medicure, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medicure will eventually generate negative long term returns. The profitability progress is the general direction of Medicure's change in net profit over the period of time. It can combine multiple indicators of Medicure, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-6 M-5.7 M
Operating Income-854 K-896.7 K
Net Loss-922 K-968.1 K
Income Before Tax-897 K-941.9 K
Total Other Income Expense Net-43 K-40.9 K
Income Tax Expense25 K23.8 K
Net Loss-922 K-875.9 K
Net Loss-654.3 K-621.6 K
Net Interest Income65 K68.2 K
Interest Income75 K71.2 K
Change To Netincome95.5 K100.2 K
Net Loss(0.09)(0.09)
Income Quality(2.25)(2.14)
Net Income Per E B T 1.03  1.82 

Medicure Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Medicure. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medicure position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medicure's important profitability drivers and their relationship over time.

Use Medicure in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medicure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicure will appreciate offsetting losses from the drop in the long position's value.

Medicure Pair Trading

Medicure Pair Trading Analysis

The ability to find closely correlated positions to Medicure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medicure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medicure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medicure to buy it.
The correlation of Medicure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medicure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medicure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medicure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Medicure position

In addition to having Medicure in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cryptocurrency Thematic Idea Now

Cryptocurrency
Cryptocurrency Theme
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Medicure Stock Analysis

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.